Treatment of early onset multiple sclerosis with suboptimal dose of interferon beta-1a.
M A Sahraian
MetadataShow full item record
Patients with early onset multiple sclerosis may develop disability at a younger age than adults. There are several reports about safety of beta interferons in childhood and juvenile MS with different doses.